OT-101
OT-01-P201
Phase 3 small_molecule active
Quick answer
OT-101 for Pancreatic Ductal Adenocarcinoma is a Phase 3 program (small_molecule) at Oncotelic Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Oncotelic Therapeutics
- Indication
- Pancreatic Ductal Adenocarcinoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active